Stocks · Health care · Biological Products, (No Diagnostic Substances)

Protalix BioTherapeutics, Inc.

PLX Clue Score38

United States Fiscal year ends December CIK 0001006281 Results filed 12 Aug 2026

Add to watchlist

What the insiders did Net selling

Individual transactions

Insider

Date

Role

Action

Price

Amount

Amos Bar-Shalev

18 Nov 2025

Director

Sell

168

$1.87

$314.16

Dexcel Pharma Technologies Ltd.

3 Jun 2021

10% owner

Sell

857,506

$2.25

$1.93M

Dexcel Pharma Technologies Ltd.

2 Jun 2021

10% owner

Sell

61,211

$2.56

$156.55K

Camber Capital Management LLC

2 Dec 2016

10% owner

Sell indirect

2,500,000

$0.32

$792.00K

Show all 12 transactions →

What was left out

Form 4 filings counted 72

Amendments (4/A) skipped 3

Filings about a different issuer 0

Unreadable filings 0

Joint filings 1

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 4

Transactions with no price 0

Shares from compensation/vesting 3,313,387

Sales filed before the plan box existed 3

History held since 5 Jan 2007